MAPK-pathway inhibition mediates inflammatory reprogramming and sensitizes tumors to targeted activation of innate immunity sensor RIG-I.
Nature communications
View this publicationNature communications
View this publicationJournal of cancer research and clinical oncology
View this publicationBlood
View this publicationInternational journal of cancer
View this publicationESC heart failure
View this publicationFrontiers in oncology
View this publicationBlood advances
View this publicationNature reviews. Neurology
View this publicationImmunity
View this publicationERJ open research
View this publication